Wednesday, 30 April 2025
  
Login

Australia's most trusted
source of pharma news

Wednesday, 30 April 2025
News

One submission wonder hits PBS

Posted 29 April 2025 AM 

It’s just a matter of hours until Australians living with an aggressive type of blood cancer will have funded access to AbbVie’s Epkinly after Federal Treasurer Jim Chalmers announced the PBS listing during his Budget Speech.

As of 1 May the pegged blockbuster will be listed on the PBS for the treatment of patients with diffuse large B-cell lymphoma (DLBCL) after two or more lines of systemic therapy.

To see the whole article, please login

Popular

Yes... but with a price reduction
Approval tainted by PBAC 'No'
Finally, a PBS listing after 1514 days
One submission wonder hits PBS
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2025 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home